首页> 外文期刊>Recent patents on drug delivery & formulation >Effect of HPMC-E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile
【24h】

Effect of HPMC-E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile

机译:HPMC-E15 LV优质聚合物对壳聚糖/果胶结肠靶向美沙拉敏基质片的释放特性和压缩特性的影响以及pH对药物释放特性影响的体外研究

获取原文
获取原文并翻译 | 示例
           

摘要

The study was designed to investigate the in vitro dissolution profile and compression characteristics of colon targeted matrix tablets prepared with HPMC E15 LV in combination with pectin and Chitosan. The matrix tablets were subjected to two dissolution models in various simulated fluids such as pH 1.2, 6, 6.8, 7.2, 5.5. The fluctuations in colonic pH conditions during IBD (inflammatory bowel disease) and the nature of less fluid content in the colon may limit the expected drug release in the polysaccharide-based matrices when used alone. The Hydrophilic hydroxyl propyl methylcellulose ether premium polymer (HPMC E15 LV) of low viscosity grade was used in the formulation design, which made an excellent modification in physical and compression characteristics of the granules. The release studies indicated that the prepared matrices could control the drug release until the dosage form reaches the colon and the addition HPMC E15 LV showed the desirable changes in the dissolution profile by its hydrophilic nature since the colon is known for its less fluid content. The hydrophilic HPMC E15 LV allowed the colonic fluids to enter into the matrix and confirmed the drug release at the target site from a poorly water soluble polymer such as Chitosan and also from water soluble Pectin. The dramatic changes occurred in the drug release profile and physicochemical characteristics of the Pectin, Chitosan matrix tablets when a premium polymer HPMC E15 LV added in the formulation design in the optimized concentration. Various drug release mechanisms used for the examination of drug release characteristics. Drug release followed the combined mechanism of diffusion, erosion, swelling and polymer entanglement. In recent decade, IBD attracts many patents in novel treatment methods by using novel drug delivery systems.
机译:该研究旨在研究HPMC E15 LV与果胶和壳聚糖组合制备的结肠靶向基质片剂的体外溶出度和压缩特性。使基质片剂在各种模拟流体(例如pH 1.2、6、6.8、7.2、5.5)中经历两种溶出模型。当单独使用IBD(炎症性肠病)期间结肠pH条件的波动以及结肠中液体含量较少的性质可能会限制基于多糖的基质中预期的药物释放。低粘度等级的亲水羟丙基甲基纤维素醚优质聚合物(HPMC E15 LV)用于配方设计,对颗粒的物理和压缩特性进行了出色的修饰。释放研究表明,所制备的基质可以控制药物的释放,直到剂型到达结肠为止。另外,HPMC E15 LV的亲水性使其溶出曲线发生了理想的变化,因为结肠以其流体含量较低而闻名。亲水性HPMC E15 LV允许结肠液进入基质,并确认了水溶性差的聚合物(如壳聚糖)和水溶性果胶在目标部位的药物释放。当以最佳浓度在配方设计中添加优质聚合物HPMC E15 LV时,果胶,壳聚糖基质片剂的药物释放曲线和理化特性发生了巨大变化。用于检查药物释放特性的各种药物释放机制。药物释放遵循扩散,侵蚀,溶胀和聚合物缠结的综合机制。在最近的十年中,IBD通过使用新型药物递送系统在新型治疗方法方面吸引了许多专利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号